What does Oxford Square Capital do?
Oxford Square Capital Corp. is a Nasdaq-listed business development company, or BDC, that invests primarily in corporate debt securities and collateralized loan obligation equity. It is a closed-end, non-diversified management investment company regulated under the Investment Company Act of 1940 and has elected regulated investment company tax treatment. In practical terms, OXSQ pools shareholder capital, adds a measured amount of leverage, and seeks to earn investment income from loans and structured-credit positions. Its investor-relations site identifies OXSQ common stock and its listed notes on the Nasdaq Global Select Market.
Why is OXSQ different from an operating company?
OXSQ does not manufacture products or sell subscriptions. Its assets are investments, its revenue is interest and distribution income, and its principal operating costs are management fees, interest expense, professional fees, and administrative expenses. Net asset value matters more than book value does for a typical industrial company because NAV is the marked value of the investment portfolio less liabilities. The company’s latest Form 10-Q for the quarter ended March 31, 2026 is therefore the central document for understanding current portfolio quality, leverage, yields, and changes in NAV.
Who are the economic stakeholders?
Common shareholders receive monthly distributions but also absorb changes in credit marks, realized losses, dilution from new share issuance, and the residual cost of debt. Noteholders rank ahead of common equity and receive contractual interest. Portfolio borrowers and CLO vehicles generate the cash flows. Oxford Square Management, the external adviser, selects investments and receives fees. This structure means the alignment among shareholders, the adviser, and the board is a core part of the analysis rather than a secondary governance detail.
How does Oxford Square Capital make money?
The business model has two main income engines. First, OXSQ owns debt investments, generally senior secured or other corporate credit positions, that pay contractual interest. Second, it owns CLO equity, the residual tranche of securitized loan pools. CLO equity can generate high cash distributions when underlying loan spreads, defaults, financing costs, and reinvestment conditions are favorable, but it is more volatile than ordinary senior debt.
Which revenue source matters most?
Debt investments produced the largest share of first-quarter 2026 investment income, but CLO equity remained economically important. The mix is revealing: debt income is usually easier to model because it begins with principal, coupon, reference rates, and credit performance. CLO equity distributions are more path-dependent. A small change in underlying loan defaults, recoveries, funding spreads, or collateral prices can have a disproportionately large effect on residual cash flows and fair values.
| Income source | Q1 2026 | Share of total | Main driver |
|---|---|---|---|
| Debt investments | $5.1M | 57.3% | Coupon income, reference rates, principal stability, non-accruals |
| CLO equity | $3.2M | 36.0% | Residual distributions after senior CLO liabilities and collateral costs |
| Other income | $0.6M | 6.7% | Fees and non-core portfolio income |
How does the cash-flow chain work?
Common equity plus listed notes funds investments.
Debt coupons and CLO cash flows create investment income.
Management fees, interest, administration, and professional costs are deducted.
NII supports distributions; gains and losses change NAV.
What did the latest quarter show?
The quarter ended March 31, 2026 was weak on both recurring earnings and asset value. According to the company’s first-quarter 2026 results release, total investment income fell to $8.9 million from $10.4 million in the fourth quarter of 2025. Net investment income declined to $4.1 million, or $0.05 per share, from $5.4 million, or $0.07 per share. Total expenses eased only modestly to $4.8 million from $5.0 million, so the revenue decline flowed through to distributable earnings.
| Metric | Q1 2026 | Q4 2025 | Interpretation |
|---|---|---|---|
| Total investment income | $8.9M | $10.4M | Lower income base reduced earnings coverage. |
| Net investment income | $4.1M / $0.05 per share | $5.4M / $0.07 per share | Recurring income fell faster than expenses. |
| Total expenses | $4.8M | $5.0M | Cost reduction did not offset lower income. |
| NAV per share | $1.32 | $1.69 | A 21.9% sequential decline signals material portfolio losses and dilution pressure. |
Why did NAV fall so sharply?
The company recorded a $25.5 million net decrease in net assets from operations. That consisted of $4.1 million of NII, $30.7 million of net realized losses, and $1.1 million of net unrealized appreciation. The realized loss overwhelmed recurring income. For a BDC, this matters twice: it reduces current net assets and it lowers the capital base available to generate future income unless replacement capital is raised.
What did portfolio activity signal?
OXSQ purchased approximately $15.8 million of investments and received only $0.4 million of repayments during Q1 2026; it made no sales. That is a net deployment posture. At the same time, the company issued about 7.2 million common shares through its at-the-market program for net proceeds of approximately $12.3 million. The capital raise supported liquidity and investment capacity, but issuing a large number of shares while NAV is under pressure can dilute per-share economics unless the issuance price and subsequent returns are sufficiently attractive.
Credit yields, non-accruals, and CLO cash flows define the portfolio
OXSQ’s headline yields are high because the portfolio bears substantial credit and structural risk. At March 31, 2026, the weighted-average yield on debt investments at current cost was 14.7%, up from 14.5% at December 31, 2025. The weighted-average effective yield on CLO equity was 7.3%, down from 8.6%. Cash distribution yield on cash-income-producing senior secured notes was 8.0%, while the comparable cash distribution yield on CLO equity was 13.6%.
How should investors interpret non-accruals?
At quarter-end, one debt investment with approximately $3.5 million of fair value was on non-accrual, meaning the company no longer recognized normal interest income from it. Preferred equity investments in one portfolio company, with aggregate fair value of about $5.2 million, were also on non-accrual. These positions represented approximately $8.7 million of fair value combined. Non-accrual levels are important because they convert a nominally high-yielding portfolio into a lower cash-earning portfolio and may foreshadow additional realized losses.
What does the credit rating score indicate?
Management’s weighted-average internal credit rating was 2.2 based on fair value and 2.4 based on principal amount at March 31, 2026. The fair-value score was unchanged from year-end, while the principal-based score worsened from 2.3. The difference suggests weaker credits may be marked below par, reducing their fair-value weight. Researchers should track migration between internal rating categories, not just the average, because a stable mean can mask deterioration in a small number of large positions.
How did Oxford Square’s strategy evolve?
The company’s history is best understood as a shift from a more traditional middle-market lending identity toward a hybrid portfolio that combines corporate credit with CLO equity. That evolution increased income potential but also made NAV, cash distributions, and valuation more sensitive to leveraged-loan cycles.
-
2003The company began operating as a BDC and elected regulated investment company treatment, establishing the pass-through distribution model that still shapes capital allocation.
-
2010sPortfolio strategy expanded beyond direct corporate loans into CLO equity, increasing exposure to residual leveraged-loan cash flows.
-
2018The company adopted the Oxford Square Capital name, reflecting the broader Oxford Funds platform and its external-management structure.
-
2020Pandemic-era credit volatility demonstrated how quickly CLO equity marks and distributions can change under stress.
-
2025OXSQ redeemed all $24.8 million of its 6.25% notes due 2026, simplifying the maturity schedule while retaining other listed unsecured notes.
-
Q1 2026A $30.7 million realized loss and $1.32 NAV per share made preservation of per-share capital the central strategic issue.
What strategic tension persists today?
That tension explains most of the company’s difficult decisions. Holding higher-risk assets can support income, but realized losses reduce the base from which future income is earned. Issuing shares can rebuild capital and liquidity, but may dilute existing owners. Reducing risk can protect NAV, but lower the portfolio yield and make the distribution harder to cover. This is the central trade-off students should identify in any strategy, SWOT, or capital-allocation analysis of OXSQ.
Who competes with OXSQ, and what is its market position?
OXSQ competes for assets and investor capital with publicly traded BDCs, private credit funds, CLO-focused closed-end funds, banks, credit hedge funds, and asset managers. Larger BDCs can often source directly originated loans, negotiate stronger covenants, diversify across more borrowers, and access cheaper financing. CLO specialists may have deeper structured-credit teams and greater scale in secondary markets.
| Competitor group | Typical advantage | Pressure on OXSQ |
|---|---|---|
| Large public BDCs | Origination scale, diversified portfolios, lower funding cost | Compete for loans and may deliver steadier NAV performance. |
| Private credit funds | Flexible mandates and institutional capital | Can bid aggressively for attractive middle-market credits. |
| CLO-focused funds | Structured-credit specialization | Compete for CLO equity and investor demand for high distributions. |
| Banks and syndicated-loan investors | Funding scale and market liquidity | Influence loan pricing, refinancing, and recovery outcomes. |
What is OXSQ’s practical advantage?
Its advantage is not dominant market share. It is a specialized mandate, a long-tenured management team, public-market access through common stock and listed notes, and the ability to combine debt with CLO equity. This can produce a differentiated income profile. However, the moat is limited by the transferability of investment talent and by the fact that competitors can buy similar syndicated loans or CLO securities. The strongest evidence of durable advantage would be consistent NAV preservation and distribution coverage across cycles; recent NAV declines make that evidence mixed.
How strong are the balance sheet and distribution?
OXSQ finances its portfolio with common equity and unsecured notes. Its 2025 annual filing describes three registered security classes at year-end: common stock, 7.75% notes due 2030, and 5.50% notes due 2028. The weighted-average stated interest rate on borrowings was 6.58% at March 31, 2026, with a weighted-average maturity of 3.3 years. Because portfolio yields are materially higher than the debt cost, leverage can enhance NII when assets perform. The same leverage magnifies NAV losses when they do not.
Is the monthly distribution covered?
The board declared monthly distributions of $0.035 per share for July, August, and September 2026, as shown in the company’s official dividend history. That equals $0.105 for a three-month period. Q1 2026 NII was $0.05 per share, less than half that quarterly distribution pace. One quarter does not establish a long-term coverage trend, and taxable income can differ from GAAP NII, but the gap is a clear monitoring signal.
What role does ATM issuance play?
ATM issuance is both a financing tool and a valuation signal. OXSQ raised $12.3 million net in Q1 2026 by issuing 7.2 million shares, an average net amount of roughly $1.71 per share. The outcome for existing owners depends on the relationship between issuance price, contemporaneous NAV, offering costs, and returns earned on reinvested proceeds. The share count reached 93.4 million at March 31 and 105.1 million by the June 30 proxy record date, underscoring how quickly per-share metrics can change.
Who owns Oxford Square Capital stock, and why does governance matter?
The company has one class of voting common stock, one vote per share. The 2026 proxy statement reported 105,058,242 shares outstanding on June 30, 2026. No holder in the proxy table was identified above 5%, which implies dispersed outside ownership rather than control by a founder or sponsor.
| Holder or group | Shares | Ownership | Why it matters |
|---|---|---|---|
| Jonathan H. Cohen, CEO | 2,419,091 | 2.3% | Meaningful economic exposure, but not voting control. |
| Saul B. Rosenthal, President | 2,203,377 | 2.1% | Aligns senior management with common-share outcomes. |
| Charles M. Royce | 2,127,470 | 2.0% | Director and minority owner of the adviser; creates related-party relevance. |
| Directors and officers as a group | 6,824,853 | 6.5% | Collective stake is material but does not control voting. |
How does external management affect incentives?
Oxford Square Management chooses investments, while Oxford Funds provides administration. CEO Jonathan H. Cohen has led OXSQ and its adviser since 2003 and also leads related Oxford investment vehicles. External management can provide a specialized platform and shared expertise, but it also requires close scrutiny of advisory fees, related-party transactions, capital raising, and allocation of investment opportunities. The board’s independent directors annually review the advisory agreement, and the proxy identifies valuation, audit, nominating and governance, and compensation committees.
Is the board independent?
The five-member board is staggered into three classes. The proxy states that Jonathan Cohen is interested because of his executive and adviser roles, while Charles Royce is interested because of his minority, non-controlling interest in Oxford Square Management. The other directors are independent under applicable BDC and Nasdaq standards. This structure provides formal oversight, but governance quality ultimately appears in valuation discipline, fee review, distribution policy, and the willingness to protect NAV per share.
What opportunities and risks could change the story?
The upside case begins with stabilization. If credit losses moderate, CLO distributions improve, and new investments earn attractive spreads, OXSQ could rebuild NII. Floating-rate corporate loans may benefit income when reference rates remain elevated, while lower market volatility can support refinancing and CLO collateral values. Redeploying ATM proceeds into performing assets could also expand total investment income.
What are the most material risks?
- Credit losses: defaults or restructurings can stop interest, reduce fair value, and create realized losses.
- CLO subordination: equity tranches receive residual cash only after senior liabilities and coverage tests are satisfied.
- Distribution pressure: persistent NII below the distribution can consume capital or force a policy change.
- Dilution: rapid ATM issuance can weaken per-share results even when total assets grow.
- Interest-rate sensitivity: lower base rates may reduce floating-rate loan income, while funding costs may adjust differently.
- External-management conflicts: fee incentives and allocation across related funds require strong board oversight.
The company’s 2025 Form 10-K provides the broader official risk-factor framework, including BDC regulation, leverage, valuation uncertainty, illiquid investments, credit concentration, and dependence on the adviser.
Why does OXSQ matter for valuation?
A conventional DCF built from revenue growth and operating margin is not the best primary framework for OXSQ. The more useful valuation anchors are NAV per share, sustainable NII per share, distribution coverage, credit-loss expectations, leverage, and the market price relative to NAV. The company’s value is the present worth of portfolio cash flows after financing costs, fees, losses, and required distributions.
| Valuation driver | Current anchor | Why it matters |
|---|---|---|
| NAV per share | $1.32 at March 31, 2026 | Starting measure of residual portfolio value. |
| NII per share | $0.05 in Q1 2026 | Core recurring earning power before gains and losses. |
| Monthly distribution | $0.035 declared for July-September 2026 | Creates income appeal but requires sustainable coverage. |
| Credit loss rate | $30.7M realized loss in Q1 2026 | Losses can overwhelm several quarters of NII. |
| Funding spread | 14.7% debt yield versus 6.58% borrowing cost | Positive spread supports earnings only if principal is preserved. |
Which scenario assumptions matter most?
A base case should model portfolio income, expenses, expected defaults, recoveries, non-accruals, debt cost, and share issuance. A stronger case would assume fewer losses, stable CLO distributions, and accretive deployment of new capital. A weaker case would combine lower floating-rate income, additional non-accruals, NAV erosion, and a distribution that remains above NII. Because the common equity is the residual claim, small changes in credit assumptions can materially alter estimated value.
What is the key takeaway from Oxford Square Capital analysis?
Oxford Square Capital is a specialized, high-income BDC whose economics are driven by corporate credit and CLO equity rather than by ordinary sales growth. Its portfolio can produce double-digit yields, but those yields are compensation for meaningful default, recovery, valuation, and structural risk. The first quarter of 2026 captured that trade-off clearly: $4.1 million of positive NII was more than offset by $30.7 million of realized losses, pushing NAV per share down to $1.32.
The company’s monthly distribution remains central to its investor profile, yet Q1 NII of $0.05 per share was well below the $0.105 three-month distribution pace. Meanwhile, share issuance expanded the capital base from 93.4 million shares at March 31 to 105.1 million by the June 30 proxy record date. That may improve liquidity and earning capacity, but it makes per-share discipline essential.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
